Comparing Mounjaro vs Wegovy: Clinical Differences
Understanding What's Best Between Mounjaro and Wegovy for Prescription Weight Loss
When evaluating what's best between Mounjaro or Wegovy, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety. Mounjaro (tirzepatide) is a dual agonist targeting both GIP and GLP-1 receptors, offering a different approach to weight management. Both are prescription-only medicines requiring clinical assessment and ongoing monitoring.
The question of what's best Mounjaro or Wegovy cannot be answered universally, as individual patient factors determine suitability. Wegovy has extensive clinical evidence through the STEP trial programme, whilst Mounjaro's SURMOUNT trials demonstrate its efficacy profile. Your prescriber will consider your medical history, current medications, and treatment goals when determining which option aligns with your circumstances. Both treatments must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Pricing and Value Comparison for Mounjaro vs Wegovy
At EverydayMeds, Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenience and treatment continuity, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 to access these competitive prices.
When comparing what's best Mounjaro or Wegovy from a value perspective, consider the total treatment journey rather than individual pen costs. Wegovy's dose escalation protocol spans 16 weeks before reaching maintenance, requiring careful planning for continuous supply. Our Getting Started bundles eliminate the complexity of ordering multiple doses separately, ensuring seamless progression through your treatment pathway. Both Mounjaro and Wegovy are available from our GPhC-registered pharmacy (#9012878) with identical service standards and clinical oversight.
Clinical Evidence: Wegovy STEP Trials vs Mounjaro SURMOUNT Studies
The STEP clinical trial programme provides robust evidence for Wegovy's efficacy in weight management. In STEP 1, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 2 demonstrated similar benefits in patients with type 2 diabetes, whilst STEP 5 confirmed sustained weight loss over two years.
When considering what's best Mounjaro or Wegovy based on clinical data, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and populations. Mounjaro's SURMOUNT trials show impressive results, but comparing percentages directly would be misleading. Both treatments have demonstrated cardiovascular benefits in their respective studies, with Wegovy's SELECT trial showing a 20% reduction in major cardiovascular events.
How Wegovy Works: GLP-1 Mechanism for Weight Loss
Wegovy's active ingredient, semaglutide, is a GLP-1 receptor agonist that works by mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines. When you inject Wegovy once weekly, it binds to GLP-1 receptors in your brain's appetite centres, reducing hunger signals and promoting feelings of fullness after smaller meals. This mechanism may also slow gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety. Additionally, Wegovy can reduce food cravings and the reward signals associated with eating, particularly for high-calorie foods. The treatment works best when combined with lifestyle modifications, as it provides the physiological support needed to maintain a reduced-calorie diet and increased physical activity levels. Unlike appetite suppressants that work through stimulant pathways, Wegovy addresses the complex hormonal systems that regulate hunger and satiety naturally.
EverydayMeds Ordering Process: Assessment to Delivery
Starting your Wegovy journey through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to gather essential medical information for prescriber review. Our qualified prescribers evaluate your eligibility based on MHRA licensing criteria, including BMI requirements and any weight-related health conditions. Standard prescriber review takes up to 3 working days, with express 24-hour review available for urgent cases. Once approved, your Wegovy pens are dispatched via next-day delivery using temperature-controlled packaging to maintain the cold chain integrity required for this prescription-only medicine. Our pharmacy team coordinates each delivery to ensure you receive your medication in optimal condition, with clear injection instructions and ongoing support available through our clinical helpline.
Storage and Practical Considerations for Wegovy Treatment
Wegovy requires refrigerated storage between 2-8°C before first use, but offers excellent travel flexibility with up to 6 weeks storage at room temperature below 30°C once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly convenient for frequent travellers or those with unpredictable schedules. The FlexTouch pen design provides accurate dosing with minimal injection discomfort, featuring a hidden needle that automatically covers after use. Dose escalation follows a strict 4-week protocol: starting at 0.25mg for weeks 1-4, progressing to 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and finally 2.4mg for maintenance. Each injection is administered once weekly on the same day, with flexibility to adjust timing by up to 3 days if needed. The pen can be injected into your abdomen, thigh, or upper arm, with rotation of injection sites recommended to prevent tissue changes.
Individual Patient Factors: Determining What's Best Mounjaro or Wegovy
The decision of what's best Mounjaro or Wegovy depends heavily on individual patient characteristics that only a qualified prescriber can properly evaluate. Factors include your current BMI, presence of type 2 diabetes or other comorbidities, previous weight loss attempts, and potential drug interactions with existing medications. Some patients may respond better to single-receptor targeting (Wegovy's GLP-1 action), whilst others might benefit from dual-receptor activation (Mounjaro's GIP+GLP-1 mechanism).
Practical considerations also influence the choice between treatments when determining what's best Mounjaro or Wegovy for your circumstances. Wegovy's superior storage flexibility and established NHS pathway through NICE TA875 may favour certain patients, whilst Mounjaro's different side effect profile might suit others better. Your prescriber will discuss these nuances during consultation, ensuring the selected treatment aligns with your lifestyle, medical needs, and long-term weight management goals.
Start Your Prescription Weight Loss Journey Today
Both Wegovy and Mounjaro are available from EverydayMeds with identical service standards and clinical oversight from our experienced team. New customers can access immediate savings with code FIRST40, whilst returning patients benefit from code DOSE25 applied at checkout. Our streamlined assessment process, rapid prescriber review, and next-day delivery ensure you can begin treatment quickly and safely. Whether you're considering what's best Mounjaro or Wegovy, our clinical team provides ongoing support throughout your weight loss journey, helping you navigate any questions or concerns that arise. Visit https://everydaymeds.co.uk/collections/wegovy to complete your assessment and take the first step towards achieving your weight management goals with professional medical guidance. Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
